Publicacións nas que colabora con Manuel Arrojo Romero (19)

2021

  1. Genetic predisposition to alcohol dependence: The combined role of polygenic risk to general psychopathology and to high alcohol consumption

    Drug and Alcohol Dependence, Vol. 221

2018

  1. Genome wide analysis of rare copy number variations in alcohol abuse or dependence

    Journal of Psychiatric Research, Vol. 103, pp. 212-218

  2. Identification of putative second genetic hits in schizophrenia carriers of high-risk copy number variants and resequencing in additional samples

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 268, Núm. 6, pp. 585-592

2016

  1. Targeted resequencing of regulatory regions at schizophrenia risk loci: Role of rare functional variants at chromatin repressive states

    Schizophrenia Research, Vol. 174, Núm. 1-3, pp. 10-16

2015

  1. An efficient screening method for simultaneous detection of recurrent copy number variants associated with psychiatric disorders

    Clinica Chimica Acta, Vol. 445, pp. 34-40

  2. Cumulative role of rare and common putative functional genetic variants at NPAS3 in schizophrenia susceptibility

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 168, Núm. 7, pp. 528-535

  3. First-time admissions for opioid treatment: Cross-sectional and descriptive study of new opioid users seeking treatment

    Neuropsychiatric Disease and Treatment, Vol. 11, pp. 2431-2440

  4. Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility

    Journal of Psychiatric Research, Vol. 66-67, pp. 38-44

2014

  1. Absence of low frequency variants associated with schizophrenia at the ultraconserved non-coding region of TCF4

    Psychiatry Research

2013

  1. Role of DISC1 interacting proteins in schizophrenia risk from genome-wide analysis of missense SNPs

    Annals of Human Genetics, Vol. 77, Núm. 6, pp. 504-512

2012

  1. Association study of nonsynonymous single nucleotide polymorphisms in schizophrenia

    Biological Psychiatry, Vol. 71, Núm. 2, pp. 169-177

  2. No evidence that major mtDNA European haplogroups confer risk to schizophrenia

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 159 B, Núm. 4, pp. 414-421

  3. Vida recreativa y consumo de cocaína y éxtasis en jóvenes

    Psicología conductual = behavioral psychology: Revista internacional de psicología clínica y de la salud, Vol. 20, Núm. 2, pp. 245-262

  4. ¿Podemos predecir el uso de psicoestimulantes en jóvenes?: un estudio a partir de un modelo de ecuaciones estructurales

    Adicciones: Revista de socidrogalcohol, Vol. 24, Núm. 4, pp. 339-346

2011

  1. Borracheras, conducción de vehículos y relaciones sexuales en jóvenes consumidores de cocaína y éxtasis

    Adicciones: Revista de socidrogalcohol, Vol. 23, Núm. 3, pp. 205-218

  2. Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: New data and meta-analysis

    Journal of Psychiatric Research, Vol. 45, Núm. 1, pp. 7-14

  3. Interaction between COMT haplotypes and cannabis in schizophrenia: A case-only study in two samples from Spain

    Schizophrenia Research, Vol. 127, Núm. 1-3, pp. 22-27

  4. ¿Tienen una personalidad distinta los adolescentes consumidores de psicoestimulantes?

    Psicothema, Vol. 23, Núm. 4, pp. 552-559

2010

  1. Testing the antagonistic pleiotropy model of schizophrenia susceptibility by analysis of DAOA, PPP1R1B, and APOL1 genes

    Psychiatry Research, Vol. 179, Núm. 2, pp. 126-129